美國壓力噴射器市場規模、佔有率和趨勢分析報告：按產品、產能、應用、最終用途、地區和細分市場分類（2026-2033 年）

美國壓力噴射器市場概述

預計到 2025 年，美國加壓輸液設備市場價值為 3.5711 億美元，預計到 2033 年將達到 5.3271 億美元，2026 年至 2033 年的複合年成長率為 5.23%。

這一成長歸因於急診和重症監護環境中對快速液體復甦的需求不斷增加、一次性加壓輸液裝置在感染控制方面的應用日益廣泛，以及需要有效液體管理的外科手術數量不斷增加。

美國外科手術數量的不斷成長是推動加壓輸液設備產業發展的主要動力。根據ScienceDirect於2024年6月發表的研究，美國每年平均每10萬人中心臟手術總數達到271.5例，反映了醫院手術負擔沉重。心血管手術和其他大型手術通常需要快速且可控地輸注液體和血液以維持血流動力學穩定，尤其是在術中出血或術後併發症的情況下。隨著手術數量的持續成長，預計醫院和手術中心將增加對包括加壓輸液袋在內的重要手術全期醫療設備的採購，這將促進美國市場的成長。

美國出血性疾病負擔的日益加重，導致對快速輸液和輸血設備的需求不斷成長。根據美國心臟協會統計，出血性中風約佔所有中風病例的13%，是需要緊急血流動力學穩定和輸血的重要患者族群。治療出血性中風和其他急性出血性急症通常需要快速補充液體，以維持腦灌注和整體生命徵象穩定。隨著這些嚴重出血事件發生率的持續上升，醫院和急診室越來越依賴壓力輸液袋進行即時可控的液體支持，這推動了美國壓力輸液袋產業的成長。

持續的產品創新和材料進步透過提升安全性、可視性和臨床效率，進一步推動了這一成長。製造商擴大採用無乳膠材料以最大限度地降低過敏風險，並採用透明輸液袋，使臨床醫生無需取下輸液袋即可直覺地檢查液位、檢測氣泡并快速識別洩漏。加固的接縫增強了耐用性，改進的壓力表和可控釋放閥則提供了更精確、更穩定的壓力輸送。此外，輕質高強度聚合物材料在保持成本效益的同時，延長了產品的使用壽命。這些創新提高了急診和手術室的使用便利性，降低了操作風險，並推動了其在美國醫療機構的廣泛應用。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

• 市場譜系展望
• 市場動態
• 商業環境分析

第4章：美國壓力噴射器市場：產品具體估算與趨勢分析

• 2025 年及 2033 年產品特定市佔率及波動分析
• 市場規模、預測與趨勢分析：按產品分類，2021-2033 年
• 可重複使用的加壓注射器
• 一次性壓力注射器

第5章：美國壓力噴射器市場：按容量分類的估算與趨勢分析

• 按產能分類的市佔率和波動分析（2025 年和 2033 年）
• 市場規模、預測與趨勢分析：依產能分類，2021-2033年
• 500 mL
• 1000 mL
• 3000 mL

第6章：美國壓力噴射器市場：按應用分類的估算與趨勢分析

• 按應用領域分類的市場佔有率和波動分析（2025 年和 2033 年）
• 市場規模、預測與趨勢分析：按應用領域分類，2021-2033年
• 緊急和緊急醫療
• 輸血及血液製品
• 手術液體管理
• 其他

第7章：美國壓力噴射器市場：依最終用途分類的估算與趨勢分析

• 按最終用途分類的市場佔有率和波動分析（2025 年和 2033 年）
• 市場規模、預測和趨勢分析：按最終用途分類，2021-2033 年
• 醫院和診所
• 門診手術中心
• 靜脈輸液中心
• 其他

第8章 競爭情勢

• 2025年公司市場分析
• 公司分類
• 公司簡介列表
  • ICU Medical, Inc.
  • Medline
  • Merit Medical Systems.
  • ASP Global（acquired by Platinum Equity）
  • Tapmedic LLC
  • Spacelabs Healthcare
  • AirLife
  • VBM Medical Inc.

U.S. Pressure Infusor Market Summary

The U.S. pressure infusor market size was estimated at USD 357.11 million in 2025 and is projected to reach USD 532.71 million by 2033, growing at a CAGR of 5.23% from 2026 to 2033. This growth is attributed to the increasing demand for rapid fluid resuscitation in emergency and critical care settings, rising adoption of disposable pressure infusors for infection control, and the growing number of surgical procedures requiring efficient fluid management.

The increasing volume of surgical procedures in the U.S. is a key driver for the pressure infusors industry. According to a study published by ScienceDirect in June 2024, the average total cardiac surgical volume in the U.S. reached 271.5 procedures per 100,000 population per year, reflecting the high procedural burden within hospital settings. Cardiac and other major surgeries often require rapid and controlled fluid or blood administration to maintain hemodynamic stability, particularly during intraoperative blood loss or postoperative complications. As surgical volumes continue to rise, hospitals and surgical centers are expected to increase procurement of essential perioperative devices, including pressure infusor bags, thereby supporting market growth in the U.S.

The growing burden of hemorrhagic conditions in the U.S. is contributing to increased demand for rapid fluid and blood administration devices. According to the American Heart Association, hemorrhagic strokes account for approximately 13% of all stroke cases, representing a significant subset of patients who may require urgent hemodynamic stabilization and blood product transfusion. Management of hemorrhagic stroke and other acute bleeding emergencies often involves rapid volume replacement to maintain cerebral perfusion and systemic stability. As the incidence of such critical bleeding events persists, hospitals and emergency departments continue to rely on pressure infusor bags for immediate and controlled transfusion support, thereby driving growth in the U.S. pressure infusor industry.

Ongoing product innovation and material advancements are further supporting the growth by improving safety, visibility, and clinical efficiency. Manufacturers are increasingly introducing latex-free materials to minimize allergy risks, along with clear or transparent pressure infusor bags that allow clinicians to visually monitor fluid levels, detect air bubbles, and quickly identify leaks without removing the IV bag. Reinforced seams enhance durability, while upgraded pressure gauges and controlled release valves provide more accurate and stable pressure delivery. Moreover, lightweight, high-strength polymer materials improve product longevity while maintaining cost-effectiveness. These innovations enhance usability in emergency and surgical settings, reduce operational risks, and encourage greater adoption across U.S. healthcare facilities.

U.S. Pressure Infusor Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. Pressure infusor market report based on product, capacity, application, and end use.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Reusable pressure infusors
• Disposable pressure infusors
• Capacity Outlook (Revenue, USD Million, 2021 - 2033)
• 500 mL
• 1000 mL
• 3000 mL
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Emergency & Critical Care Resuscitation
• Blood and Blood Product Transfusion
• Surgical Fluid Management
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Infusion Centers
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Capacity
  • 1.2.3. Application
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising demand for rapid fluid resuscitation in emergency, trauma, and critical care settings.
    • 3.2.1.2. Increasing number of surgical procedures
    • 3.2.1.3. Growing adoption of disposable pressure infusors
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Competition from alternative fluid delivery systems
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
  • 3.2.5. Technology Overview
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. U.S. Pressure Infusor Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Product Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Reusable pressure infusors
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Disposable pressure infusors
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Pressure Infusor Market: Capacity Estimates & Trend Analysis

• 5.1. Capacity Mode Segment Dashboard
• 5.2. Capacity Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Capacity, 2021 to 2033 (USD Million)
• 5.4. 500 mL
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. 1000 mL
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. 3000 mL
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Pressure Infusor Market: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. Application Market Share Movement Analysis, 2025 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Emergency & Critical Care Resuscitation
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Blood and Blood Product Transfusion
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Surgical Fluid Management
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Pressure Infusor Market: End Use Estimates & Trend Analysis

• 7.1. End use Segment Dashboard
• 7.2. End use Market Share Movement Analysis, 2025 & 2033
• 7.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
• 7.4. Hospitals and Clinics
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Ambulatory Surgical Centers
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Infusion Centers
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Market Position Analysis, 2025
• 8.2. Company Categorization
• 8.3. Company Profiles/Listing
  • 8.3.1. ICU Medical, Inc.
    • 8.3.1.1. Participant Overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Medline
    • 8.3.2.1. Participant Overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Merit Medical Systems.
    • 8.3.3.1. Participant Overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. ASP Global (acquired by Platinum Equity)
    • 8.3.4.1. Participant Overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Tapmedic LLC
    • 8.3.5.1. Participant Overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Spacelabs Healthcare
  • 8.3.7. AirLife
    • 8.3.7.1. Participant Overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. VBM Medical Inc.
    • 8.3.8.1. Participant Overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. Pressure Infusor market, by Product, 2021 - 2033 (USD Million)
• Table 4 U.S. Pressure Infusor market, by Capacity, 2021 - 2033 (USD Million)
• Table 5 U.S. Pressure Infusor market, by application, 2021 - 2033 (USD Million)
• Table 6 U.S. Pressure Infusor market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 U.S. Pressure Infusor market: Market outlook
• Fig. 5 U.S. Pressure Infusor market: Segment outlook
• Fig. 6 U.S. Pressure Infusor market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 U.S. Pressure Infusor Market Driver Impact
• Fig. 9 U.S. Pressure Infusor market Restraint impact
• Fig. 10 U.S. Pressure Infusor market, Product outlook key takeaways (USD Million)
• Fig. 11 U.S. Pressure Infusor market: Product movement analysis (USD Million)
• Fig. 12 Reusable pressure infusors market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 13 Disposable pressure infusors market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 14 U.S. Pressure Infusor market,Capacity outlook key takeaways (USD Million)
• Fig. 15 U.S. Pressure Infusor market: Capacity movement analysis (USD Million)
• Fig. 16 500 mL market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 17 1000 mL market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 18 3000 mL market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 U.S. Pressure Infusor market, Application outlook key takeaways (USD Million)
• Fig. 20 U.S. Pressure Infusor market: Application Mode movement analysis (USD Million)
• Fig. 21 Emergency & Critical Care Resuscitation market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Blood and Blood Product Transfusion market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Surgical Fluid Management market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Others market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 U.S. Pressure Infusor market, End Use outlook key takeaways (USD Million)
• Fig. 26 U.S. Pressure Infusor market: End Use movement analysis (USD Million)
• Fig. 27 Hospitals and Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 28 Ambulatory Surgical Centers market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 29 Infusion Centers market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 31 Company categorization
• Fig. 32 Company market position analysis, 2025
• Fig. 33 Strategic framework